We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
New research published in the Clinical Cancer Research has found that modified versions of the vaccinia virus have boosted immunotherapy in sarcoma tumours; a hard-to-treat cancer.